Get the Stockscreener App
149.58
0.44%
0.65
After Hours:
149.40
-0.18
-0.12%
Health Care Select Sector Spdr Stock (XLV) Forecast
The Health Care Select Sector Spdr (XLV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $143.56, representing a -4.02% decrease from the current price of $149.58. The highest analyst price target is $156.57, and the lowest is $130.56.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XLV Price Target
Average 155.33
(+3.84% Upside)
Is Health Care Select Sector Spdr (XLV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.00 | Neutral |
| STOCH(9,6) | 84.31 | Sell |
| STOCHRSI(14) | 97.46 | Sell |
| MACD(12,26) | 1.2088 | Buy |
| ADX(14) | 22.04 | Neutral |
| William %R | -11.42 | Sell |
| CCI(14) | 157.86 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
147.46
Buy
|
147.81
Buy
|
| MA20 |
147.02
Buy
|
146.87
Buy
|
| MA50 |
143.37
Buy
|
145.46
Buy
|
| MA100 |
145.42
Buy
|
145.66
Buy
|
| MA200 |
147.54
Buy
|
145.16
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, XLV could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on XLV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63 indicates that XLV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 84.31 indicates that XLV is oversold. This means that XLV price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 97.46 indicates that XLV is oversold. This suggests that XLV price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.04 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 157.86 indicates that XLV is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term XLV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Health Care Select Sector Spdr financial reports and earnings history, Health Care Select Sector Spdr (XLV) stock could reach $196.71 by 2030, $362.60 by 2040 and $482.04 by 2050. See the projected annual prices until 2050 of the Health Care Select Sector Spdr stock below:
- Health Care Select Sector Spdr (XLV) is expected to reach an average price of $289.70 in 2035, with a high prediction of $289.73 and a low estimate of $280.64. This indicates an $93.68% rise from the last recorded price of $149.58.
- Health Care Select Sector Spdr (XLV) stock is projected to chart a bullish course in 2040, with an average price target of $360.87, representing an $141.26% surge from its current level. The forecast ranges from a conservative $355.62 to a sky-high $362.60.
- Our analysts predict Health Care Select Sector Spdr (XLV) to jump 175.53% by 2045, soaring from $409.80 to an average price of $412.13, potentially reaching $420.33. While $409.80 is the low estimate, the potential upside is significant.
- Health Care Select Sector Spdr (XLV) stock is expected to climb by 2050, reaching an average of $481.87, a $222.15% jump from its current level. However, a wide range of estimates exists, with high and low targets of $482.04 and $471.78, respectively, highlighting the market's uncertainty.
Health Care Select Sector Spdr Stock (XLV) Year by Year Forecast
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2025
Health Care Select Sector Spdr Stock (XLV) is expected to reach an average price of $150.30 in 2025, with a high prediction of $170.05 and a low estimate of $130.56. This indicates an +0.48% rise from the last recorded price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $145.74 | $130.56 | $156.57 | -2.57% |
| May, 2025 | $157.86 | $141.16 | $158.93 | +5.54% |
| June, 2025 | $158.30 | $154.69 | $159.89 | +5.83% |
| July, 2025 | $159.21 | $153.89 | $162.58 | +6.44% |
| August, 2025 | $159.56 | $155.40 | $162.09 | +6.67% |
| September, 2025 | $165.68 | $159.84 | $166.61 | +10.77% |
| October, 2025 | $165.45 | $164.21 | $169.54 | +10.61% |
| November, 2025 | $165.65 | $160.88 | $167.09 | +10.74% |
| December, 2025 | $162.39 | $161.04 | $170.05 | +8.56% |
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2026
The predicted value for Health Care Select Sector Spdr (XLV) in 2026 is set at an average of $182.98. Estimates vary from a peak of $202.72 to a trough of $163.24, indicating an +22.33% surge from the present price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $170.58 | $163.24 | $175.34 | +14.04% |
| February, 2026 | $174.47 | $170.14 | $174.82 | +16.64% |
| March, 2026 | $178.93 | $171.02 | $180.09 | +19.62% |
| April, 2026 | $176.89 | $176.22 | $181.16 | +18.26% |
| May, 2026 | $177.91 | $172.62 | $178.64 | +18.94% |
| June, 2026 | $181.30 | $176.35 | $181.33 | +21.20% |
| July, 2026 | $187.27 | $181.00 | $189.01 | +25.20% |
| August, 2026 | $188.78 | $184.74 | $189.81 | +26.21% |
| September, 2026 | $193.53 | $187.91 | $193.85 | +29.38% |
| October, 2026 | $198.10 | $191.18 | $199.63 | +32.44% |
| November, 2026 | $200.78 | $196.97 | $202.45 | +34.23% |
| December, 2026 | $193.33 | $193.28 | $202.72 | +29.25% |
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Health Care Select Sector Spdr (XLV) is $201.04, with a high forecast of $212.81 and a low forecast of $189.27. This indicates an +34.40% increase from the last price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $198.19 | $190.80 | $198.22 | +32.50% |
| February, 2027 | $199.88 | $197.31 | $202.05 | +33.63% |
| March, 2027 | $205.35 | $196.06 | $207.02 | +37.28% |
| April, 2027 | $201.91 | $200.53 | $209.61 | +34.99% |
| May, 2027 | $200.55 | $192.97 | $201.92 | +34.08% |
| June, 2027 | $201.29 | $192.62 | $202.82 | +34.57% |
| July, 2027 | $206.17 | $196.34 | $208.13 | +37.83% |
| August, 2027 | $203.26 | $203.12 | $212.81 | +35.89% |
| September, 2027 | $204.13 | $195.18 | $204.56 | +36.47% |
| October, 2027 | $190.41 | $189.27 | $203.29 | +27.30% |
| November, 2027 | $201.68 | $191.29 | $202.97 | +34.83% |
| December, 2027 | $205.07 | $196.27 | $205.14 | +37.10% |
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2028
In 2028, Health Care Select Sector Spdr (XLV) is projected to reach an average price of $203.91, with a high projection of $215.39 and a low estimate of $192.43. This indicates an +36.32% rise from the last price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $196.85 | $196.25 | $206.02 | +31.60% |
| February, 2028 | $193.39 | $192.98 | $204.12 | +29.29% |
| March, 2028 | $205.54 | $192.43 | $206.06 | +37.41% |
| April, 2028 | $210.35 | $201.59 | $210.46 | +40.63% |
| May, 2028 | $209.82 | $207.43 | $215.39 | +40.27% |
| June, 2028 | $208.04 | $206.39 | $210.87 | +39.08% |
| July, 2028 | $207.03 | $205.57 | $209.35 | +38.41% |
| August, 2028 | $199.21 | $198.73 | $208.66 | +33.18% |
| September, 2028 | $208.99 | $198.76 | $209.58 | +39.72% |
| October, 2028 | $209.47 | $206.40 | $211.39 | +40.04% |
| November, 2028 | $206.72 | $202.35 | $209.42 | +38.20% |
| December, 2028 | $209.54 | $205.28 | $209.86 | +40.09% |
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2029
The 2029 price forecast for Health Care Select Sector Spdr Stock (XLV) is $210.30 on average, with a high prediction of $229.68 and a low estimate of $190.92. This represents an +40.59% increase from the previous price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $211.48 | $205.80 | $214.07 | +41.38% |
| February, 2029 | $211.15 | $209.51 | $214.15 | +41.16% |
| March, 2029 | $210.34 | $208.88 | $213.50 | +40.62% |
| April, 2029 | $208.76 | $205.34 | $210.77 | +39.56% |
| May, 2029 | $205.35 | $201.36 | $210.59 | +37.28% |
| June, 2029 | $211.32 | $204.85 | $211.46 | +41.28% |
| July, 2029 | $216.29 | $210.69 | $216.60 | +44.60% |
| August, 2029 | $220.80 | $215.97 | $222.17 | +47.61% |
| September, 2029 | $228.69 | $220.39 | $229.10 | +52.89% |
| October, 2029 | $226.79 | $225.55 | $229.05 | +51.62% |
| November, 2029 | $220.71 | $219.97 | $229.68 | +47.55% |
| December, 2029 | $192.44 | $190.92 | $223.91 | +28.65% |
Health Care Select Sector Spdr Stock (XLV) Price Forecast for 2030
Health Care Select Sector Spdr Stock (XLV) is expected to reach an average price of $202.60 in 2030, with a high forecast of $217.62 and a low forecast of $187.57. This signifies an +35.44% surge from the last price of $149.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $196.09 | $190.76 | $196.71 | +31.09% |
| February, 2030 | $197.93 | $196.13 | $199.81 | +32.32% |
| March, 2030 | $197.50 | $196.78 | $198.97 | +32.04% |
| April, 2030 | $197.67 | $195.13 | $198.98 | +32.15% |
| May, 2030 | $198.52 | $196.68 | $200.24 | +32.72% |
| June, 2030 | $201.24 | $195.66 | $202.03 | +34.53% |
| July, 2030 | $208.39 | $201.51 | $208.51 | +39.32% |
| August, 2030 | $213.80 | $208.56 | $213.86 | +42.93% |
| September, 2030 | $214.44 | $212.01 | $215.09 | +43.36% |
| October, 2030 | $216.61 | $211.19 | $217.62 | +44.81% |
| November, 2030 | $201.75 | $197.78 | $217.19 | +34.88% |
| December, 2030 | $200.49 | $187.57 | $203.77 | +34.04% |
0.92%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):